Status:
COMPLETED
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
Lead Sponsor:
Organon and Co
Conditions:
Asthma, Bronchial
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
15-55 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats.
Detailed Description
The duration of treatment is 2 weeks.
Eligibility Criteria
Inclusion
- Increased sensitivity to cat allergen proven by positive allergy testing, and by decreased lung function and increased symptoms of allergic rhinitis (runny nose) upon exposure to cats.
Exclusion
- Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection.
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2003
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00092105
Start Date
April 1 2002
End Date
January 28 2003
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.